BEACOPP-14 VS BEACOPP-ESC IN PATIENTS WITH HODGKIN'S LYMPHOMA FROM POOR-PROGNOSIS GROUP: PRELIMINARY RESULTS OF PROSPECTIVE RANDOMIZED MULTYCENTER STUDY

被引：0
|
作者：
Kriachok, I. [1 ]
Titorenko, I. [1 ]
Filonenko, K. [1 ]
Aleksik, E. [1 ]
Novosad, O. [1 ]
Kadnikova, T. [1 ]
Kushchevoy, E. [1 ]
Martinchik, A. [1 ]
Pastushenko, Y. [1 ]
机构：
[1] Natl Canc Inst, Kiev, Ukraine
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1366
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [21] BEACOPP chemotherapy is an active and feasible regimen in children and adolescents with advanced stage Hodgkin's disease: Preliminary results from Children's Cancer Group study CCG-59704.
    Kelly, KM
    Hutchinson, RJ
    Sposto, R
    Weiner, M
    Lones, M
    Perkins, SL
    Massey, V
    Cohen, R
    BLOOD, 2002, 100 (11) : 776A - 776A
  • [22] Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
    Borchmann, Peter
    Haverkamp, Heinz
    Diehl, Volker
    Cerny, Thomas
    Markova, Jana
    Ho, Anthony D.
    Eich, Hans-Theodor
    Mueller-Hermelink, Hans Konrad
    Kanz, Lothar
    Greil, Richard
    Rank, Andreas
    Paulus, Ursula
    Smardova, Lenka
    Huber, Christoph
    Doerken, Bernd
    Nerl, Christoph
    Krause, Stefan W.
    Mueller, Rolf-Peter
    Fuchs, Michael
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) : 4234 - 4242
  • [23] BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
    Diehl, V
    Franklin, J
    Hasenclever, D
    Tesch, H
    Pfreundschuh, M
    Lathan, B
    Paulus, U
    Sieber, M
    Rueffer, JU
    Sextro, M
    Engert, A
    Wolf, J
    Hermann, R
    Holmer, L
    Stappert-Jahn, U
    Winnerlein-Trump, E
    Wulf, G
    Krause, S
    Glunz, A
    von Kalle, K
    Bischoff, H
    Haedicke, C
    Duehmke, E
    Georgii, A
    Loeffler, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3810 - 3821
  • [24] Fertility in male patients with Hodgkin's disease results from the German Hodgkin Lymphoma Study Group
    Sieniawski, M
    Josting, A
    Reineke, T
    Diehl, V
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 : 118 - 118
  • [25] Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
    Damaschin, Carla
    Goergen, Helen
    Kreissl, Stefanie
    Pluetschow, Annette
    Breywisch, Frank
    Mathas, Stephan
    Meissner, Julia
    Soekler, Martin
    Topp, Max S.
    Vucinic, Vladan
    Zimmermann, Andreas
    von Tresckow, Bastian
    Fuchs, Michael
    Engert, Andreas
    Borchmann, Peter
    Eichenauer, Dennis A.
    LEUKEMIA, 2022, 36 (02) : 580 - 582
  • [26] Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
    Carla Damaschin
    Helen Goergen
    Stefanie Kreissl
    Annette Plütschow
    Frank Breywisch
    Stephan Mathas
    Julia Meissner
    Martin Sökler
    Max S. Topp
    Vladan Vucinic
    Andreas Zimmermann
    Bastian von Tresckow
    Michael Fuchs
    Andreas Engert
    Peter Borchmann
    Dennis A. Eichenauer
    Leukemia, 2022, 36 : 580 - 582
  • [27] PROSPECTIVE-STUDY WITH COMBINED LOW-DOSE CHEMOTHERAPY AND ZIDOVUDINE IN 37 PATIENTS WITH POOR-PROGNOSIS AIDS-RELATED NON-HODGKIN LYMPHOMA
    TIRELLI, U
    ERRANTE, D
    OKSENHENDLER, E
    SPINA, M
    VACCHER, E
    SERRAINO, D
    GASTALDI, R
    REPETTO, L
    RIZZARDINI, G
    CARBONE, A
    BERTOLA, G
    MANDELLI, F
    MONFARDINI, S
    GISSELBRECHT, C
    ANNALS OF ONCOLOGY, 1992, 3 (10) : 843 - 847
  • [28] A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)
    Ballova, V
    Rüffer, JU
    Haverkamp, H
    Pfistner, B
    Müller-Hermelink, HK
    Dühmke, E
    Worst, P
    Wilhelmy, M
    Naumann, R
    Hentrich, M
    Eich, HT
    Josting, A
    Löffler, M
    Diehl, V
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 124 - 131
  • [29] Fertility in male patients with Hodgkin's disease - Results from the German Hodgkin Lymphoma Study Group (GHSG).
    Sieniawski, M
    Josting, A
    Breuer, K
    Diehl, V
    Engert, A
    BLOOD, 2004, 104 (11) : 370A - 370A
  • [30] First Results From a Randomized Phase 2 Study of Cabazitaxel vs an Androgen Receptor-Targeted Agent in Patients With Poor-Prognosis Castration-Resistant Prostate Cancer
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 17 - 18
12345